While AZBio and its members recognize that the State of Arizona and the legislature must work diligently to balance the State Budget – which includes implementation of SB1475 and a 5% rate cut to providers of healthcare services – the end result may ultimately increase the state’s healthcare spend rather than reduce it.Continue reading
Category Archives: AZBio News
Study of triple-negative breast cancer is most cited in AACR journal
TGen, Baylor, US Oncology study revealed therapeutic drug targets for aggressive form of breast cancerContinue reading
Success Stories: Pinnacle Transplant Honored in Phoenix
Pinnacle Transplant Technologies takes home Phoenix Chamber Impact Award for business of the yearContinue reading
How Research and Technology at Phoenix Children’s are leading to better patient outcomes.
Hospital Week 2015: A look at the work being done at Phoenix Children’s Hospital Continue reading
ASU professor Charles Arntzen named Fast Company’s Most Creative Person in Business
Arizona State University Biodesign Institute researcher Charles Arntzen has been chosen as the No. 1 honoree among Fast Company’s annual “100 Most Creative People in Business” for his leadership role in developing ZMapp, a therapeutic produced in tobacco to fight Ebola.Continue reading
Arizona Poison Centers Welcome Approval of New Snake Antivenom, Plan Research
Tucson, Phoenix Toxicologists To Assess DrugsContinue reading
TGen-UCSF study published in Neuro-Oncology provides comprehensive look at brain cancer treatments
New clinical trial at UCSF, based on TGen genomic research, uses multiple drugs to cross blood-brain barrier and attack glioblastoma tumorsContinue reading
Capital For Emerging Growth Companies: Six House Bills To Watch
The success of the Jumpstart Our Business Startups (JOBS) Act in the biotech industry means that the work of the Subcommittee on Capital Markets and Government Sponsored Enterprises has taken on increased importance for emerging biotech companies. Current bills being considered could help to further support the search for breakthrough treatments at the next generation of emerging growth biotech companies.Continue reading
Tumor profiling goes public: HTG Molecular Diagnostics sets terms for $50 million IPO
Tumor profiling goes public: HTG Molecular Diagnostics sets terms for $50 million IPO
Opportunity Alert: Business Operations Manager, Phoenix Children’s Hospital
Position Summary:
This position is responsible for developing and managing annual research budget, productivity analysis, financial reporting, and analysis for research administration. Continue reading